PBH
HealthcarePrestige Consumer Healthcare Inc.
$62.47
+$1.25 (+2.04%)
Jan 5, 2026
Price History (1Y)
Analysis
Prestige Consumer Healthcare Inc. is a healthcare company that operates in the sector of drug manufacturers - specialty & generic, within the industry of Drug Manufacturers - Specialty & Generic. With a market capitalization of $3.07B and annual revenues of $1.11B, the company has a significant scale of operations. It also employs approximately 600 individuals. The company's financial health is characterized by profitability margins, returns on equity and assets, and balance sheet metrics. Prestige Consumer Healthcare Inc.'s gross margin stands at 56.9%, while its operating and profit margins are 29.1% and 18.1%, respectively. In terms of returns, the company boasts a return on equity of 11.3% and a return on assets of 6.4%. Its balance sheet is marked by a debt-to-equity ratio of 57.04 and cash holdings of $119.11M, against total debts of $1.04B. Prestige Consumer Healthcare Inc.'s valuation context is evident in its P/E ratios, growth rates, and dividend payment details. The company's trailing twelve-month P/E stands at 15.16, while the forward P/E is 12.92. Earnings have contracted by 21.1% year-over-year, whereas revenues have decreased by 3.4%. Dividend information is not available for this company.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Visit website →Key Statistics
- Market Cap
- $3.07B
- P/E Ratio
- 15.16
- 52-Week High
- $90.04
- 52-Week Low
- $57.25
- Avg Volume
- 421.64K
- Beta
- 0.40
Company Info
- Exchange
- NYQ
- Country
- United States
- Employees
- 600